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A 37-year-old patient, with a history of ar-
rhythmogenic right ventricular cardiomyopathy 
(ARVC) and involvement of the left ventricle, 
was admitted due to repetitive implantable car-
dioverter-defibrillator (ICD) shocks and syncope 
in the course of ventricular tachycardia (VT) and 
ventricular fibrillation (VF).  
He had previously experienced multiple ap-
propriate therapies for VT, and had undergone 
endocardial/epicardial ablation procedures with 
Figure 1. Chest X-ray showing final implantable cardioverter-defibrillator system after the procedure, standing position, 
postero-anterior projection.
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a temporary reduction of arrhythmia burden. He 
had been previously implanted with an ICD (dual-
coil passive-fixation lead). Prior treatment with 
sotalol and amiodarone was not successful.
Implantable cardioverter-defibrillator inter-
rogation showed intermittent under-sensing of VT 
and VF, which lead to a delay in therapy. R-wave 
amplitude during sinus rhythm was 2–3 mV. 
The initial plan of  treatment was to exchange 
the right ventricular (RV) ICD lead, in order to 
achieve appropriate R-wave amplitude and sensing.
After reviewing  voltage maps from previous abla-
tion procedures — RV voltage maps showed  RV 
potentials of over 4 mV only in the area around the 
His bundle, with the rest of the RV being scarred. 
Epicardial maps showed higher potential amplitude 
only over the lateral and posterior basal surface of 
the left ventricle. Therefore it was decided to im-
plant an epicardial sensing lead in the region with 
sufficient signal amplitude. An epicardial lead was 
implanted from left micro-thoracotomy approach 
(R-wave amplitude 20 mV, threshold 0.8V/0.4 ms, 
impedance 800 Ohm) and connected instead of the 
endocardial pace-sense channel, together with high-
voltage channels of the previously implanted lead, to 
the ICD (Fig. 1). During follow-up, the patient expe-
rienced VT and VF episodes that were appropriately 
detected and treated with antytachycardia pacing or 
shocks. This approach has proven feasible, when the 
conventional ICD system cannot be applied.
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